Nevertheless, because of TG2 involvement in other neurodegenerative diseases (e.g., Alzheimer’s disease [21,22]), further research is also needed to address whether the observed increase in relative V4a and V4b expression is restricted to MS pathology or if it is a common feature during neurodegenerative processes. Here, TGM2 is linked to early-onset autosomal dominant Alzheimer disease.